Growth Metrics

Prelude Therapeutics (PRLD) Amortizatization of Intangibles (2024 - 2026)

Prelude Therapeutics' Amortizatization of Intangibles history spans 3 years, with the latest figure at $387000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 589.87% to $387000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $837000.0, a 79.81% decrease, with the full-year FY2025 number at $371000.0, down 92.0% from a year prior.
  • Amortizatization of Intangibles hit $387000.0 in Q1 2026 for Prelude Therapeutics, up from $188000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for PRLD hit a ceiling of $3.4 million in Q4 2024 and a floor of -$584000.0 in Q3 2025.
  • Historically, Amortizatization of Intangibles has averaged $599666.7 across 3 years, with a median of $392000.0 in 2024.
  • Biggest five-year swings in Amortizatization of Intangibles: tumbled 248.98% in 2025 and later soared 589.87% in 2026.
  • Tracing PRLD's Amortizatization of Intangibles over 3 years: stood at $3.4 million in 2024, then tumbled by 94.53% to $188000.0 in 2025, then surged by 105.85% to $387000.0 in 2026.
  • Business Quant data shows Amortizatization of Intangibles for PRLD at $387000.0 in Q1 2026, $188000.0 in Q4 2025, and -$584000.0 in Q3 2025.